Evmann Investments Holding BV @EvmannBV

Evmann Investments Holding BV is a holding company which currently has investments in ophthalmology and orthopedics sectors. evmann.nl Amsterdam Joined October 2021

Tweets

18
Followers

8
Following

64
Likes

10

EIN Presswire: Press Releases @EINPresswirePR

4 years ago

Evmann Holding Searches For New Investment Opportunities in Eastern Europe s.einnews.com/lHSBoQ7hgi

0 1 0 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

Evmann Creates Roadmap to Facilitate its Development into a Global Unicorn Company - EIN Presswire einnews.com/article/566428… via @ein_news

0 0 0 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

Happy New Year! Best wishes for peace and prosperity in 2022!

0 0 0 0 0

View Details

EIN Presswire: Press Releases @EINPresswirePR

5 years ago

Dutch Evmann Investments Holding BV, the umbrella organization of "VSY Biotechnology GmbH-Germany" and "Alsanza Medizintechnik und Pharma GmbH-Germany" is searching for a substantial investment opportunity in the United States․ s.einnews.com/0u9iNpwLB4

0 1 1 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

Evmann’s ‘Eyes’ are on New Investments at the Eyecelerator@AAO 2021 in New Orleans germanhealthreview.com/article/556710…

0 0 0 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

Evmann BV Chairman Dr. Ercan Varlıbaş attended a productive investment meeting with Hungarian Prime Minister Viktor Orban

0 0 0 0 0

View Details

EIN Presswire: Press Releases @EINPresswirePR

5 years ago

VSY Biotechnology GmbH Launched AcrivaUD Trinova Pro C Pupil Adaptive®, the First and Only Trifocal IOL that Combines Patented Enhanced Sinusoidal Vision Technology (SVT®) with Pupil Adaptive Design at the ESCRS 2021 Congress in Amsterdam․ s.einnews.com/E0Mpi5p-Ik

0 1 2 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

As Evmann Holding BV Board members, we continue to visit subsidiaries, VSY GMBH's headquarters in Stuttgart was our next destination and we had a chance to observe ready-to-dispatch Acriva Trinova Pro and Enova IOL products in the storehouse.

0 0 1 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

As Evmann Holding BV Board members, we have visited the head office of subsidiary company Alsanza GMBH in Germany. Thank you, Cristina Popa, Rosemarie Koch, Orçun Demircan and Rene Veber for their gracious hospitality throughout our stay. #AlsanzaGMBH #biotechnologie #Investment

0 0 1 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

We would like to thank prominent names of Ophthalmology Dr. Ike Ahmed, Dr. Karsten Klabe and Dr. Hakan Kaymak for their admirable presentations and support for the launch of Acriva Trinova Pro C Pupil Adaptive. @ikekahmed @ESCRSofficial

0 1 4 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

VSY GMBH held a satellite symposium and has just launched a game-changer presbyopia-correcting IOL; Acriva Trinova Pro C Pupil Adaptive.

1 0 0 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

An affiliate company of Evmann Holding BV, VSY Biotechnology GMBH took place at European Society of Cataract and Refractive Surgeons (ESCRS) 2021 with an amazing satellite symposium and impressive booth. #escrs2021

1 0 0 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

We are thrilled and honored to announce that the appointment of industry expert Mr. Can Ongen to the Evmann Holding BV’s Board of Directors. Mr. Can Ongen will be leading the Business Expansion Committee of the Board. ophthalmologybreakingnews.com/evmann-holding…

0 0 1 0 0

View Details

Evmann Investments Holding BV @EvmannBV

5 years ago

Special thanks to; Mr. Erik Rijnierse, Mr. Robert Forterie, Ms. Alexis Alleyne Mr. Alexander de Saegher, Mr. Ferruh T. Tigli, Dr. Ercan Varlibas, Ms. Nagihan S. Karpuz, Mr. Fatih Ergin Mr. Suleyman Can Varlibas.